SILK News and Press, Silk Road Medical Inc. From 02/03/22

SUNNYVALE, Calif., Feb. 03, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report financial results for the fourth quarter and full year 2021 after market close on Thursday...

SUNNYVALE, Calif., Feb. 02, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will be participating in the 11th Annual SVB Leerink Global Healthcare Conference. Silk...

SUNNYVALE, Calif., Dec. 30, 2021 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will be participating in the upcoming 40th Annual J.P. Morgan Healthcare Conference. ...

Silk Road Medical (SILK +6.2%) CEO Erica J. Rogers buys 2,500 shares of the company's stock in a transaction dated Tuesday, November 30th. The stock was bought at an average cost of $41.30 per share, for a total transaction value of $103K. SEC Filing. SILK's 98% of shareholdings are held...

SUNNYVALE, Calif., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will be participating in a fireside chat at the upcoming Piper Sandler 33 rd Annual Virtu...

Silk Road Medical, Inc. (SILK) Q3 2021 Earnings Conference Call November 09, 2021 04:30 PM ET Company Participants Marissa Bych - IR Erica Rogers - Chief Executive Officer Lucas Buchanan - Chief Financial Officer and Chief Operating Officer Andy Davis - Chief Commercial Officer Conference Cal...

Image source: The Motley Fool. Silk Road Medical, inc (NASDAQ: SILK) Q3 2021 Earnings Call Nov 9, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Silk Road Medical, inc (SILK) Q3 2021 Earnings Call Transcript

Silk Road Medical (NASDAQ:SILK): Q3 GAAP EPS of -$0.40 misses by $0.11. Revenue of $24.7M (+22.9% Y/Y) misses by $1.53M. Press Release Cash, cash equivalents, and short-term investments were $122.8M as of September 30, 2021. For further details see: Silk Road Medical EPS misses by $0.11...

SUNNYVALE, Calif., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the quarter ended September 30, 2021. “I am incredibly proud of our tea...

SUNNYVALE, Calif., Nov. 02, 2021 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will be participating in a fireside chat at the upcoming Stifel 2021 Virtual Healthcare Confe...